NATURE’S SUNSHINE PRODUCTS, INC. Long-term Line of Credit, Noncurrent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Long-term Line of Credit, Noncurrent of $0 as of 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermLineOfCredit · last filed 2019-03-08
- 2018-12-31: Long-term Line of Credit, Noncurrent $0.00.
- 2018-03-31: Long-term Line of Credit, Noncurrent $7.72M.
- 2017-12-31: Long-term Line of Credit, Noncurrent $13.18M.
- 2017-09-30: Long-term Line of Credit, Noncurrent $19.18M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-08 |
| 2018-03-31 | $7.72M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $13.18M 10-K · filed 2019-03-08 |
| 2017-09-30 | $19.18M 10-Q · filed 2017-11-09 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |